Year archive

Active Biotech — 2011 filings

All 56 regulatory filings released by Active Biotech (ACTI) in 2011, sourced directly from the official regulator.

56 Filings

2011 Period

2011 filings (56)

Filing	Released	Lang
Active Biotechs valberedning utsedd AGM Information	2011-11-10	Swedish
Active Biotech's election committee appointed AGM Information	2011-11-10	English
Interim / Quarterly Report 2011 Interim / Quarterly Report 9M 2011	2011-11-03	Swedish
Interim / Quarterly Report 2011 Interim / Quarterly Report 9M 2011	2011-11-03	English
Information angående Active Biotechs läkemedelskandidat laquinimod Regulatory Filings	2011-11-02	Swedish
Information regarding Active Biotech's candidate drug laquinimod Regulatory Filings	2011-11-02	English
LÄKEMEDELSKANDIDATEN LAQUINIMOD - EN LOVANDE UNIK ORAL BEHANDLING MOT RRMS Regulatory Filings	2011-10-19	Swedish
INVESTIGATIONAL LAQUINIMOD DEMONSTRATES ITS POTENTIAL AS A NEW ORAL TREATMENT FOR RRMS Regulatory Filings	2011-10-19	English
Active Biotechs prostatacancerprojekt TASQ presenterat i Journal of Clinical Oncology Regulatory Filings	2011-09-20	Swedish
Active Biotech's Prostate Cancer Project TASQ Featured in Journal of Clinical Oncology Legal Proceedings Report	2011-09-20	English
Earnings Release 2011 Earnings Release H2 2011	2011-08-11	Swedish
Interim / Quarterly Report 2011 Interim / Quarterly Report H2 2011	2011-08-11	English
RESULTAT FRÅN FAS III-STUDIEN BRAVO STÄRKER LAQUINIMODS UNIKA PROFIL FÖR BEHANDLING AV MULTIPEL SKLEROS Earnings Release FY 2011	2011-08-01	Swedish
RESULTS OF PHASE III BRAVO TRIAL REINFORCE UNIQUE PROFILE OF LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT Earnings Release FY 2011	2011-08-01	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-06-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-06-30	English
Active Biotech presenterar på Jefferies 2011 Global Healthcare Conference Investor Presentation	2011-06-08	Swedish
Active Biotech to Present at the Jefferies 2011 Global Healthcare Conference Regulatory Filings	2011-06-08	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-05-31	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-05-31	English
Active Biotech presenterar data rörande projektet 57-57 på EULAR Regulatory Filings	2011-05-26	Swedish
Active Biotech Presents Data regarding the 57-57 Project at EULAR Legal Proceedings Report	2011-05-26	English
Årsstämma i Active Biotech AB AGM Information	2011-05-06	Swedish
Annual General Meeting of Active Biotech AB AGM Information	2011-05-06	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-04-29	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-04-29	English
Interim / Quarterly Report 2011 Interim / Quarterly Report Q1 2011	2011-04-28	Swedish
Interim / Quarterly Report 2011 Interim / Quarterly Report Q1 2011	2011-04-28	English
Active Biotechs samarbetspartner Teva kommenterar resultaten från studien DEFINE i multipel skleros Regulatory Filings	2011-04-26	Swedish
Active Biotech's partner Teva comments on DEFINE study results in Multiple Sclerosis Regulatory Filings	2011-04-26	English
Active Biotech och Ipsen tecknar brett samarbetsavtal för utveckling och kommersialisering av TASQ inom uro-onkologi Regulatory Filings	2011-04-18	Swedish
Active Biotech and Ipsen enter into a broad partnership for the co-development and commercialization of TASQ in uro-oncology Regulatory Filings	2011-04-18	English
Valberedningen i Active Biotech föreslår ytterligare en ny styrelseledamot Board/Management Information	2011-04-14	Swedish
Active Biotech's nomination committee proposes election of an additional new board member Board/Management Information	2011-04-14	English
LAQUINIMOD FÖR ORAL BEHANDLING AV MULTIPEL SKLEROS GAV BÅDE SIGNIFIKANT MINSKAD SJUKDOMSAKTIVITET OCH FUNKTIONSNEDSÄTTNING MED BIBEHÅLLEN GOD SÄKERHET OCH TOLERABILITET Regulatory Filings	2011-04-12	Swedish
ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT SIGNIFICANTLY REDUCED DISEASE ACTIVITY AND DISABILITY PROGRESSION WHILE PROVIDING GOOD SAFETY AND TOLERABILITY Regulatory Filings	2011-04-12	English
Teva håller webbkonferens avseende resultaten från fas III-studien ALLEGRO av oral laquinimod för behandling av multipel skleros Regulatory Filings	2011-04-11	Swedish
Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis Regulatory Filings	2011-04-11	English
Årsredovisning 2010 Active Biotech AB (publ) Report Publication Announcement	2011-04-06	Swedish
Annual Report 2010 Active Biotech AB (publ) Report Publication Announcement	2011-04-06	English
Annual Report 2011 Annual Report FY 2011	2011-04-06	Swedish
Annual Report 2011 Annual Report FY 2011	2011-04-06	English
Kallelse till årsstämma AGM Information	2011-04-05	Swedish
Notice of Annual General Meeting of Shareholders AGM Information	2011-04-05	English
Helén Tuvesson utsedd till forskningschef på Active Biotech Board/Management Information	2011-03-15	Swedish
Helén Tuvesson appointed as new Chief Scientific Officer at Active Biotech Board/Management Information	2011-03-15	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-02-28	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2011-02-28	English
Active Biotechs prostatacancerprojekt TASQ presenterat på 2011 Genitourinary Cancers Symposium Regulatory Filings	2011-02-18	Swedish
Active Biotech's TASQ prostate cancer project presented at 2011 Genitourinary Cancers Symposium Regulatory Filings	2011-02-18	English
Earnings Release 2010 Earnings Release FY 2010	2011-02-10	Swedish
Interim / Quarterly Report 2010 Interim / Quarterly Report FY 2010	2011-02-10	English
Active Biotech genomför riktad nyemission om 375 miljoner kronor Share Issue/Capital Change	2011-01-27	Swedish
Active Biotech successfully completes private placement of SEK 375 million Share Issue/Capital Change	2011-01-27	English
Active Biotech offentliggör placering av nya aktier Share Issue/Capital Change	2011-01-26	Swedish
Active Biotech announces launch of private placement of new shares Capital/Financing Update	2011-01-26	English

Filings by year

2026 11 filings
2025 41 filings
2024 45 filings
2023 32 filings
2022 42 filings
2021 48 filings
2020 41 filings
2019 45 filings
2018 38 filings
2017 33 filings
2016 40 filings
2015 40 filings
2014 49 filings
2013 58 filings
2012 58 filings
2011 56 filings
2010 62 filings
2009 55 filings
2008 28 filings
2007 8 filings